Lars Wortmann
Impact in
- Cell Biology top 10%
- Microtubule and mitosis dynamics
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Ubiquitin and proteasome pathways 3
- DNA Repair Mechanisms 2
- Protein Degradation and Inhibitors 2
- Chemical Synthesis and Analysis 2
- RNA Research and Splicing 2
-
- Catalytic C–H Functionalization Methods 2
- Co-authors
- Dieter Enders (5 shared papers)René Peters (1 shared paper)Michael Brands (4 shared papers)Laura M. Luh (2 shared papers)Philipp M. Cromm (2 shared papers)Katrin Juenemann (2 shared papers)U. Scheib (2 shared papers)Dominik Mumberg (6 shared papers)
- Journals
- Molecular Cell (2 papers)Cancer Research (2 papers)Angewandte Chemie International Edition (2 papers)Chemistry - A European Journal (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- GermanyUnited KingdomSouth Sudan
In The Last Decade
Lars Wortmann
17 papers receiving 706 citations
Peers
Comparison fields: 5 of 61
- Cell Biology 156
- Oncology 216
- Molecular Biology 465
- Organic Chemistry 178
- Hematology 28
Countries citing papers authored by Lars Wortmann
This map shows the geographic impact of Lars Wortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wortmann more than expected).
Fields of papers citing papers by Lars Wortmann
This network shows the impact of papers produced by Lars Wortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wortmann. The network helps show where Lars Wortmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Wortmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 163 | |
| 2 | 2019 | 148 | |
| 3 | 2020 | 142 | |
| 4 | 2000 | 111 | |
| 5 | 2020 | 40 | |
| 6 | 2018 | 19 | |
| 7 | 2011 | 17 | |
| 8 | 2019 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2017 | 12 | |
| 11 | 2013 | 12 | |
| 12 | 1999 | 8 | |
| 13 | 2020 | 6 | |
| 14 | 2021 | 4 | |
| 15 | 2002 | 4 | |
| 16 | 2004 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2,2-dimethyl-1,3-dioxan-5-one. A dihydroxyacetone equivalent for asymmetric synthesis | 1997 | 0 |
About Lars Wortmann
Lars Wortmann is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cell Biology and Infectious Diseases, having authored 18 papers that have together received 715 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), DNA Repair Mechanisms (2 papers), Protein Degradation and Inhibitors (2 papers), Microtubule and mitosis dynamics (2 papers), HIV/AIDS drug development and treatment (2 papers), Catalytic C–H Functionalization Methods (2 papers), Chemical Synthesis and Analysis (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cell Biology (156 citations), Oncology (216 citations), Molecular Biology (465 citations), Organic Chemistry (178 citations) and Hematology (28 citations). Lars Wortmann has collaborated with scholars based in Germany, United Kingdom and South Sudan. Frequent co-authors include Dieter Enders, René Peters, Michael Brands, Laura M. Luh, Philipp M. Cromm, Katrin Juenemann, U. Scheib, Dominik Mumberg, Gerhard Siemeister and Uwe Eberspächer. Their work appears in journals such as Molecular Cell, Cancer Research, Angewandte Chemie International Edition, Chemistry - A European Journal and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.